Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Tiotropium 18microgram inhalation powder capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tiotropium bromide (substance) |
Inferred relationship |
Some |
|
Tiotropium bromide monohydrate (substance) |
Is a |
False |
Tiotropium bromide (substance) |
Inferred relationship |
Some |
|
Tiotropium bromide monohydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Tiotropium bromide (substance) |
Inferred relationship |
Some |
|
Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tiotropium bromide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely formoterol fumarate dihydrate 12 microgram and tiotropium (as tiotropium bromide) 18 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tiotropium bromide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tiotropium (as tiotropium bromide) 2.5 microgram/1 actuation conventional release solution for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tiotropium bromide (substance) |
Inferred relationship |
Some |
1 |
Tiotropium (as tiotropium bromide) 1.25 microgram/actuation solution for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tiotropium bromide (substance) |
Inferred relationship |
Some |
1 |
Ciclesonide 400 microgram and formoterol fumarate dihydrate 12 microgram and tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tiotropium bromide (substance) |
Inferred relationship |
Some |
1 |
Tiotropium bromide anhydrous (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Tiotropium bromide (substance) |
Inferred relationship |
Some |
|
Tiotropium (as tiotropium bromide) 10 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tiotropium bromide (substance) |
Inferred relationship |
Some |
1 |